CANL Company Profile and Key Details

The stock is currently trading near its 52-week low $0.00 and $0.01. With a market capitalization of about $93.32 thousand, CannLabs, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.40). Key stats such as the average daily volume over the past year has been around 1.12 thousand shares, volume is running light vs its 52-week average. Headquartered in Denver, CO, CannLabs, Inc. operates in the Industrials sector and the Specialty Business Services industry. Led by CEO Mark C. Mirken, the company employs approximately 37 people and listed since December 10, 2012. CannLabs, Inc. provides cannabis testing laboratory services in the United States.

Average 10-day trading volume of 41.13 thousand shares is significantly above the 3-month average of 16.38 thousand, indicating heightened recent market interest.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Valuation shows CannLabs, Inc. trading at a premium to the broader market with a P/E of 0.09.

Our AI price prediction model suggests that CannLabs, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

CannLabs, Inc. trades at a P/E ratio of 0.09, slightly below the S&P 500 average, with a price-to-sales ratio of 0.02 and a price-to-book ratio of 0.03 suggesting the stock is closer to book value. The P/FCF stands at 0.12, also below market averages.